Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4201 USD | -2.28% |
|
+18.34% | -43.66% |
Jul. 02 | Traws Pharma Files for Potential Sale of 128.9 Million Shares | MT |
Jun. 21 | Traws Pharma, Inc. Announces Resignation of Steven M. Fruchtman as President and Chief Scientific Officer, Oncology | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
10.88M | - | - | - | |||
46.56B | - | |||||
41.67B | ||||||
41.16B | ||||||
32.4B | - | |||||
28.18B |
- Stock Market
- Equities
- TRAW Stock
- Charts Traws Pharma, Inc.
- Sector Chart